Simvastatin Addition to Standard of Care Improves Long-Term Survival in Patients With Cirrhosis After Variceal Bleed: An Open Label Randomized…
Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled clinical trial Thierry Thévenot et al. Highlights…
Endoscopic ultrasound-guided gallbladder versus bile duct drainage for first-line therapy of malignant biliary obstruction: international multicenter trial Benedetto Mangiavillano et…
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis Arun J. Sanyal et al. for the ESSENCE Study Group Abstract…
ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease Singal, Ashwani K.et al. Abstract Malnutrition, defined as deficiency, excess,…
Noncontrast Magnetic Resonance Imaging vs Ultrasonography for Hepatocellular Carcinoma Surveillance: A Randomized, Single-Center Trial Hyungjin Rhee et al. Abstract Background &…
Colangite biliare primitiva: AIFA approva la rimborsabilità di elafibranor Redazione15 Aprile 2025 L’Agenzia Italiana del Farmaco (AIFA) ha annunciato l’imminente rimborsabilità del farmaco…
Molecular Testing and Targeted Therapies in Hepatobiliary Cancers. A Review Diamantis I. Tsilimigras et al. Abstract Importance Hepatobiliary cancers are heterogeneous…
Journal of Viral Hepatitis: Volume 31, Issue S2 Pages: 1-60 December 2024 Previous Issue|Next Issue Export Citation(s) The publication of this supplement has…
Glucagon-like peptide-1 receptor agonist use is associated with a lower risk of major adverse liver-related outcomes: a meta-analysis of observational…
Hemochromatosis William C. Palmer, MD Fernando F. Stancampiano, MD Hemochromatosis is an inheritable condition that mainly affects White populations of…
Cholangioscopy for Primary Sclerosing Cholangitis With Biliary Strictures Using Texture and Color Enhancement Imaging and Red Dichromatic Imaging. Tomohiro Ishi…
US drug agency approves potent painkiller — the first non-opioid in decades The FDA’s nod for suzetrigine bolsters confidence in…
A Clinical Update on MASLD Grace Y. Zhang, MD; Danielle Brandman, MD, MAS Metabolic dysfunction–associated steatotic liver disease (MASLD; formerly…
AGA Clinical Practice Update on Management of Portal Vein Thrombosis in Patients With Cirrhosis: Expert Review Jessica P.E. Davis et al.…
Surveillance for Hepatocellular Carcinoma in Cirrhosis: End of Monopoly for Serum Alpha Fetoprotein Lung-Yi Mak ∙ Man-Fung Yuen Hepatocellular carcinoma (HCC) is the final…
A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis Tracey L. Marsh et al Abstract…
Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial Susan…
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis Kris V. Kowdley et al. Abstract Background Primary biliary cholangitis is…
Primary biliary cholangitis Prof Atsushi Tanaka et al. Summary Primary biliary cholangitis is a chronic, autoimmune, cholestatic disease that mainly…
Primary drainage of distal malignant biliary obstruction: A comparative network meta-analysis Gaetano Lauri et al. Abstract Background The effectiveness of…
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis Gideon M Hirschfield et al. Abstract Background: Effective treatments for patients…
Reinfection After Hepatitis C Virus Treatment—Keep Testing, Keep Treating Marianne Martinello, MBBS, PhD1; Gail V. Matthews, MBChB, PhD1 More than 2 million people in the…
Hepatitis C Virus Reinfection Among People Who Inject DrugsLong-Term Follow-Up of the HERO Study Alain H. Litwin et al. Key PointsQuestion What…
Il nostro sito Web utilizza i cookies e quindi raccoglie informazioni sulla tua visita per migliorare la consultazione del sito (analizzando le tue scelte), per mostrarti i contenuti dei social media e annunci pertinenti.Consulta la nostra pagina cookies per ulteriori dettagli o accetta facendo clic sul pulsante "Accetta".
Di seguito puoi scegliere quale tipo di cookies consentire su questo sito.Fare clic sul pulsante "Salva impostazioni cookies" per applicare la scelta.
FunzionaliIl nostro sito web utilizza cookie funzionali. Questi cookie sono necessari per far funzionare il nostro sito web.
AnaliticiIl nostro sito Web utilizza cookie analitici per consentire di analizzare il nostro sito Web e ottimizzarlo ai fini a.o. l'usabilità.
Social mediaIl nostro sito web inserisce cookie di social media per mostrarti contenuti di terze parti come YouTube e FaceBook. Questi cookie possono tracciare i tuoi dati personali.
PubblicitariIl nostro sito web inserisce cookie pubblicitari per mostrarti pubblicità di terze parti in base ai tuoi interessi. Questi cookie possono tracciare i tuoi dati personali.
AltriIl nostro sito web inserisce cookie di terze parti da altri servizi di terze parti che non sono analitici, social media o pubblicitari.
Questo contenuto è bloccato. Accetta i cookies nella categoria '%CC%' per visualizzare questo contenuto.